• Allowing more radiation to reach the tumor while sparing healthy tissues
• Combining the strengths of antibodies (long circulation) with small molecules (fast clearance) for safer delivery
• Offering a path to more effective and tolerable treatments and addressing potential complexity in the clinic

New Company for 2026